Please login to the form below

Not currently logged in
Email:
Password:

Concordia

This page shows the latest Concordia news and features for those working in and with pharma, biotech and healthcare.

Daily Brief: Immunotherapy firm Advaxis cuts back, Pfizer wins price gouging appeal

Daily Brief: Immunotherapy firm Advaxis cuts back, Pfizer wins price gouging appeal

Market manipulation, or so called ‘price gouging’was also a factor. Four firms were investigated for ‘abusing a dominant position’to overcharge: Concordia and Actavis UK, and Pfizer and Flynn.

Latest news

  • Concordia accused of overcharging NHS for thyroid drug Concordia accused of overcharging NHS for thyroid drug

    Concordia accused of overcharging NHS for thyroid drug. The pharma firm said to have ‘abused’its position within the UK market. ... Markets Authority (CMA), which says Concordia “abused its dominant position to overcharge the NHS”.

More from news
Approximately 1 fully matching, plus 1 partially matching documents found.

Latest Intelligence

  • Pharma deals in September 2015 Pharma deals in September 2015

    Transformational deals. The two largest deals announced this month were Cinven's sale of Amdipharm Mercury (AMCo) to Concordia Healthcare and Actelion's move to acquire ZS Pharma, at $3.5bn ... level. AMCo's commercial footprint reaches across 100

  • Medius Deal Watch table for March 2015 Medius Deal Watch table for March 2015

    J&J divest subsidiary marketing vascular devices. 1, 944. Covis / Concordia.

  • Pharma deals in March 2015 Pharma deals in March 2015

    Covis (asset). Concordia. 1.2. 8.2. NR. Hyperion. Horizon. 1.1. 9.6. 35%.

  • Deal Watch table for March 2014 Deal Watch table for March 2014

    341. Revive Pharmaceuticals/ Concordia Healthcare. Product acquisition. Donnatal, adjunctive therapy for IBS and acute enterocolitis (marketed).

More from intelligence
Approximately 0 fully matching, plus 4 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
EY Life Sciences

Our global reach Against a backdrop of regulatory, digital, financial and global transformation, Life Sciences companies are finding integration and...

Latest intelligence

Developing advocacy in the pharmaceutical industry.
The importance of advocacy programmes...
GDPR and events. What does the pharma industry need to know?
Many people in the pharma industry still aren’t following the rules set out by the GDPR when it comes to running events and attending tradeshows. But with eye-watering fines for...
Digital trends in B2B sales - how far behind is Pharma?
The modern approach to B2B sales is data-driven, and enabled by digital tools....

Infographics